Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Michigan Entertainment Wire.
Press releases published on June 23, 2025
Triple Hair Group signe une entente de licence pour le marché brésilien avec Aché
GlobeNewswire
·
June 23, 2025
L'entente de licence accorde à Aché les droits exclusifs de vente du médicament sur ordonnance Thérapie-07 de Triple Hair au Brésil. L'entente comprend des paiements initiaux, des paiements d'étape et des redevances sur les ventes futures potentielles. …
Parsons Named #1 Program Management Firm by Engineering News-Record
GlobeNewswire
·
June 23, 2025
CHANTILLY, Va., June 23, 2025 (GLOBE NEWSWIRE) -- Parsons Corporation (NYSE: PSN) announced today that the company was ranked #1 on Engineering News-Record's (ENR) annual list of Top 50 Program Management Firms. This ranking, which is two spaces ahead of …
Qingdao stories of multinational companies | IBARMIA, Spain: Qingdao's business environment supports global expansion and builds a new hub for high-end manufacturing
GlobeNewswire
·
June 23, 2025
QINGDAO, China, June 23, 2025 (GLOBE NEWSWIRE) -- On June 18, the 6th Qingdao Multinationals Summit was held as scheduled. In order to better tell the "Qingdao story" of the business environment during the summit, Phoenix.com Qingdao specially planned the …
Historias de Qingdao sobre empresas multinacionales | IBARMIA, España: El entorno empresarial de Qingdao impulsa la expansión global y consolida un nuevo centro de manufactura de alto nivel
GlobeNewswire
·
June 23, 2025
QINGDAO, China, June 23, 2025 (GLOBE NEWSWIRE) -- El 18 de junio se llevó a cabo, según lo previsto, la sexta Cumbre de Empresas Multinacionales en Qingdao. Con el objetivo de mostrar mejor la "historia de Qingdao" en cuanto a su entorno empresarial …
New study published in Journal of Experimental Medicine reveals a CARMIL2 mutation with therapeutic antitumor potential
GlobeNewswire
·
June 23, 2025
Press Release Carmil Therapeutics to develop next-generation immunotherapies based on this innovation Paris …